V
Venus Medtech
Developing and industrializing international advanced interventional artificial cardiac valve systems
About Venus Medtech
Venus Medtech is a company that specializes in the development and commercialization of medical devices for structural heart diseases, with a focus on transcatheter heart valve therapies in China. The company is publicly traded on the Hong Kong Stock Exchange under the ticker 2500.HK.
Read full description
Venus Medtech's primary business involves creating and selling innovative solutions for heart conditions. A key part of its strategy includes acquiring other companies, such as Cardiovalve, to enhance its product offerings and expand its technological capabilities. The company serves the medical community, providing advanced tools for cardiac surgeons and interventionists. Its business model revolves around research and development, manufacturing, and sales of these specialized medical devices.
At a glance
- Founded
- 2009
- Headquarters
- Hangzhou, China
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Venus Medtech.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later1 investor entered at this stage
DCP Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Venus Medtech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Venus Medtech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.